Researchers at the University of California, San Diego have developed what they call a Smart Petri Dish that could be used to rapidly screen new drugs for toxic interactions or identify cells in the early stages of cancer circulating through blood.
Known as Pepfactants, new peptide technology can control the emulsions and foams used in a wide range of industry processes and could impact a range of products from petroleum to specialty chemicals and therapeutic drugs.
Using a novel polymer to coat paramagnetic iron oxide particles, a research team at the University of Washington in Seattle has created a nanoparticulate magnetic resonance (MR) imaging agent that targets certain tumor cells.
Scientists have determined the atomic crystal structure and functional mechanism of an enzyme essential for eliminating unwanted, non-nutritional compounds such as drugs, industrial chemicals, and toxic compounds from the body.
New research may lead to the development of a new breed of multimodal contrast agents that could work within a host of medical imaging platforms ? from ultrasound and computed tomography to magnetic resonance imaging and molecular imaging.
A nanoparticle-based drug delivery concept in which an applied magnetic field directs the accumulation in tumor cells of custom-designed, drug-filled nanocarriers has been demonstrated by University at Buffalo researchers.
University of Arkansas researchers have created assemblies of nanowires that show potential in applications such as armor, flame-retardant fabric, bacteria filters, oil cracking, controlled drug release, decomposition of pollutants and chemical warfare agents.